Medication adherence in cardiovascular medicine

BMJ. 2021 Aug 11:374:n1493. doi: 10.1136/bmj.n1493.

Abstract

Cardiovascular disease is the leading cause of death globally. While pharmacological advancements have improved the morbidity and mortality associated with cardiovascular disease, non-adherence to prescribed treatment remains a significant barrier to improved patient outcomes. A variety of strategies to improve medication adherence have been tested in clinical trials, and include the following categories: improving patient education, implementing medication reminders, testing cognitive behavioral interventions, reducing medication costs, utilizing healthcare team members, and streamlining medication dosing regimens. In this review, we describe specific trials within each of these categories and highlight the impact of each on medication adherence. We also examine ongoing trials and future lines of inquiry for improving medication adherence in patients with cardiovascular diseases.

Publication types

  • Review

MeSH terms

  • Cardiovascular Agents / economics
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / mortality
  • Clinical Trials as Topic
  • Cognitive Behavioral Therapy / statistics & numerical data
  • Comorbidity
  • Drug Costs / legislation & jurisprudence*
  • Humans
  • Medication Adherence / statistics & numerical data*
  • Patient Care Team / ethics
  • Patient Education as Topic / methods*
  • Polypharmacy
  • Practice Guidelines as Topic
  • Professional Role / psychology
  • Reminder Systems / instrumentation

Substances

  • Cardiovascular Agents